These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33819196)

  • 1. A novel immune-related prognostic signature in epithelial ovarian carcinoma.
    Su T; Zhang P; Zhao F; Zhang S
    Aging (Albany NY); 2021 Apr; 13(7):10289-10311. PubMed ID: 33819196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
    Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W
    Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma.
    Wang X; Li X; Wei L; Yu Y; Hazaisihan Y; Tao L; Jia W
    J Ovarian Res; 2024 Jul; 17(1):150. PubMed ID: 39030559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
    Liu J; Xu W; Li S; Sun R; Cheng W
    Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
    [No Abstract]   [Full Text] [Related]  

  • 7. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
    Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
    BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
    Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
    Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
    Front Oncol; 2020; 10():1588. PubMed ID: 33014809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer.
    Xu S; Gao X; Qiu J; Hong F; Gao F; Wang X; Zhang S
    Aging (Albany NY); 2023 Feb; 15(4):1052-1073. PubMed ID: 36801818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
    Zhang S; Li Z; Dong H; Wu P; Liu Y; Guo T; Li C; Wang S; Qu X; Liu Y; Che X; Xu L
    Sci Prog; 2021; 104(1):36850421997286. PubMed ID: 33661721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
    Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
    World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel immune prognostic model in gastric cancer.
    Li Y; He X; Fan L; Zhang X; Xu Y; Xu X
    Clin Transl Oncol; 2021 Apr; 23(4):846-855. PubMed ID: 32857339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.